PERRIGO Co plc
PRGO- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001585364
No open-market purchases or sales by PERRIGO Co plc insiders were filed in the last 90 days; 340 institutions reported holding it in 13F filings for Q2 2026, worth $1.67B in total; Maverick Capital is the only superinvestor holding it.
Q3 2022 vs. Q2 2022
How the institutions holding PERRIGO Co plc changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 337 | 2 | 337 | +2 |
| Shares | 130.5M | 37 | 128.3M | −2.26M (−1.7%) |
| Value | $5.29B | $1.00K | $4.58B | −$718.2M (−13.6%) |
2 institutions that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (52)
Institutions that held PERRIGO Co plc at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (50)
Institutions that held PERRIGO Co plc at the end of Q2 2022 and filed for Q3 2022 without it.
Not filed for Q3 2022 yet (2)
Institutions that held PERRIGO Co plc at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Brewin Dolphin Wealth Management Ltd | 26 | $1.00K |
| Brewin Dolphin Ltd | 11 | $0 |